Brief: Maravai LifeSciences Outlook FY Revenue USD 300-325 Million
07/08/2023 21:05
Aug 07 (Reuters) - Maravai LifeSciences outlook FY adjusted EBITDA USD 70-80 million. * outlook FY adjusted EPS USD 0.04-0.08
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million